Earnings History for GlaxoSmithKline plc (GSK)
|
Expand Research on GSK
| Next EPS Date | 7/25/13 *Est. | EPS Growth Rate | -35.7% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -12.6% | Revenue Growth Rate | +61,577.8% *Last Qtr. |
| Average % Move 1-Wk after EPS | +6.6% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/24/13 | Q113 | GBP0.27 | N/A | N/A | GBP6.47B | GBP6.64B | N/A / N/A | N/A | +2.2% | Details | |
| 2/6/13 | Q412 | GBP0.33 | N/A | N/A | GBP6.8B | GBP6.98B | N/A / N/A | N/A | +15.8% | Details | |
| 10/31/12 | Q312 | GBP0.23 | N/A | N/A | GBP6.53B | GBP7.1B | N/A / N/A | N/A | +15.1% | Details | |
| 4/25/12 |
Q112 | $0.42 | $0.91 | -$0.49 | $10.49M | $10.88M | $0.93 / $10.79B | N/A | +10.6% | Details | |
| 4/27/11 | Q111 | $0.48 | N/A | N/A | $10.54B | N/A | N/A / N/A | N/A | +25.2% | Details | |
| 10/21/10 |
Q310 | $28.20 | $27.30 | +$0.90 | N/A | N/A | N/A / N/A | N/A | +27.6% | Details |
